// App-Quantinova.ai

BIOM-36 : SERIAL ASSESSMENT OF MEASURABLE RESIDUAL DISEASE IN MEDULLOBLASTOMA LIQUID BIOPSIES

Researchers

Presenter

  • Anthony Pak-Yin Liu

Principal Investigators

  • Kyle Smith

  • Rahul Kumar

  • Leena Paul

  • Tong Lin

  • Kendra Maass

  • Kristian Pajtler

  • Laure Bihannic

  • Brent Orr

  • David Ellison

  • Richard Gilbertson

  • Arzu Onar-Thomas

  • Amar Gajjar

  • Giles Robinson

  • Paul Northcott

Medical Centers

  • St. Jude Children's Research Hospital, Memphis, TN, USA

  • German Cancer Research Centre, Heidelberg, Germany

  • Cancer Research UK Cambridge Centre, CRUK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK

  • THE UNIVERSITY OF HONG KONG, Hong Kong

  • Memphis, TN, USA

Locations

  • United States

  • Hong Kong

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Medulloblastoma

  • Brain cancer

Biomarkers

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • NCT00085202

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved